Immunotherapy combo before kidney surgery shows promise in High-Risk patients
NCT ID NCT05148546
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 33 times
Summary
This study tests whether giving immunotherapy before surgery can shrink kidney tumors and reduce the chance of cancer coming back. About 69 adults with a high-risk type of kidney cancer will receive one of three drug combinations before their operation. The goal is to see which treatment works best and is safe enough to use before surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Netherlands Cancer Institute
Amsterdam, North Holland, 1066CX, Netherlands
-
Royal Free London NHS Foundation Trust
London, NW3 2QG, United Kingdom
Conditions
Explore the condition pages connected to this study.